Qosina Corp. is pleased to announce the appointment of four new board members
Ronkonkoma, NY, USA, November 14, 2018— Qosina Corp. and its Qosmedix division are pleased to announce the appointment of four new board members: Pat Alesia, Robert Beckman, Ari Hoffman and Bruce Williams. The new members join the existing board of Stuart Herskovitz, Janis Herskovitz and Scott Herskovitz.
Stuart Herskovitz, Qosina’s founder and chairman of the board, said, “We are delighted to welcome these talented leaders to our board of directors. Their combined industry expertise, operational leadership and proven track record of profitability will help propel Qosina and Qosmedix into the next stage of growth.”
“We are confident Qosina and Qosmedix will benefit greatly from the guidance of the new members due to their business acumen and expertise,” said Scott Herskovitz, president and CEO of Qosina. “Their experience across global markets will undoubtedly add a valuable perspective to our board.”
Mr. Alesia is the former senior vice president, CFO and chief administrative officer of Griffon Corporation (NYSE: GFF), where he was employed for nearly 40 years. After his retirement in 2013, he commenced serving Griffon Corporation in a consulting role. In 2015, Mr. Alesia formed Alesia Consultants, lending his vast experience in finance, accounting, compliance, risk management and cyber security as a strategic consultant to other corporate clients.
Mr. Beckman has served in corporate and industry leadership for several decades and has supported the growth and development of a wide range of global healthcare companies. He formed The Channel Group, an advisory business that provides support to global healthcare companies. Mr. Beckman also was a founder of BIO and NYBIO, where he served as chairman and in board leadership positions.
Mr. Hoffman is currently the CEO of Scotch & Soda USA and has been a fashion industry executive for over 30 years, working at leading brands including Yves Saint Laurent, Christian Lacroix, St. John, Lacoste, GANT and Benetton. He has been ranked on the fashion industry’s Power 100 list and served on the retail advisory board of NYC and Co.
Mr. Williams’ professional background crosses many end-product markets and a wide variety of product applications, the majority being with healthcare OEMs. Mr. Williams’ previous roles include engineering manager, vice president of sales and marketing, COO and CEO during his tenure with Value Plastics, Inc.
Founded in 1980, Qosina is a leading global supplier of OEM single-use components to the medical and pharmaceutical industries. Qosina’s philosophy is to address its customers’ need to reduce time to market by providing thousands of stock components. The company’s vast catalog features more than 5,000 products shown in full-scale illustrations on a one-centimeter grid. Qosina offers free samples of most items, low minimum order requirements, just-in-time delivery, modification of existing molds, and new product design and development. Qosina is ISO 9001, ISO 13485 and ISO 14001 certified, and operates in a 95,000 square-foot facility with an ISO Class 8 Clean Room. To learn about Qosina’s full component offering, visit the company’s newly redesigned e-commerce website at www.qosina.com, or call +1 (631) 242-3000.
Qosmedix is an ISO 9001 and ISO 14001 certified global supplier to the cosmetic, skin care, spa and salon industries. Founded on the concept of maintaining hygienic practices during beauty consultations, the company has expanded to provide an array of high quality products that offer convenience and value to its customers. The vast inventory includes brushes, swabs, applicators, disposable spa wear, jars, bottles and more. For assistance with sample requests, orders or customization inquiries, please contact a customer specialist by phone: +1 (631) 242-3270, fax: +1 (631) 242-3291, or email: [email protected]. Ask to receive the latest catalog, or visit www.qosmedix.com to view the complete product line. Qosmedix is a division of Qosina, a leading international supplier of components to the medical and pharmaceutical industries.
###
View website